TABLE 2

Affinities of the H3R for agonists and antagonists

Data reported as Ki were converted to pKi. For recombinant receptors all values refer to the H3R of 445 aa.

pKi
RatMouseGuinea PigMonkeyDogHuman
Imidazole-Containing Agonists
 HistamineNative
8.27a7.92 ± 0.54 (high)b7.58a7.88c8.50 ± 0.08d8.59 ± 0.08d
8.28e6.09 ± 0.61 (low)b8.18 ± 0.15d8.63f
7.92g8.08c
8.29 ± 0.03d
8.20 ± 0.10e
8.30f
8.13i
7.82j
Recombinant
7.87g8.78 ± 0.10k7.81g
8.57f8.58f
7.69l7.88l
5.70 ± 0.15m8.20 ± 0.04n
7.89 ± 0.07n8.55 ± 0.01k
8.00 ± 0.10o
8.03 ± 0.06p
8.30 ± 0.10q
8.60 ± 0.00r
8.50s
8.40 ± 0.20t
 RAMHNative
8.88a,e7.91 ± 0.09 (high)b8.49a8.50c8.93 ± 0.19d9.15 ± 0.06d
8.82g6.67 ± 0.21 (low)b8.63 ± 0.25d8.82c
8.71 ± 0.08d9.48 ± 0.16u9.16 ± 0.07v
8.95i10.07 ± 0.16u
8.71 ± 0.08v
Recombinant
8.72g8.40j9.55 ± 0.04k8.67g
8.44l8.56l
6.40 ± 0.20m8.91 ± 0.07n
8.62 ± 0.07n9.41 ± 0.05k
9.35 ± 0.20v8.20 ± 0.10o
8.36 ± 0.07p
8.92 ± 0.11q
9.00 ± 0.10r
9.16 ± 0.08v
8.56w
 SAMHNative
7.30a5.93 ± 0.04b7.30a7.69c7.79 ± 0.11d7.49c
7.33 ± 0.06d7.63 ± 0.18d8.33 ± 0.18d
7.11i
Recombinant7.20 ± 0.10o
7.60 ± 0.20r
 NAMHNative
8.92g8.67 ± 0.27d8.76c9.15 ± 0.09d9.41 ± 0.06d
8.78 ± 0.13d9.99 ± 0.24u9.08c
9.15i10.31 ± 0.24u
Recombinant8.61g
8.82g9.22 ± 0.03n
8.70 ± 0.09n8.95j8.40 ± 0.10o
9.00 ± 0.10r
9.80s
 ImmepipNative
9.30g9.50 ± 0.66 (high)b8.68 ± 0.34d9.25 ± 0.06d9.58 ± 0.06d
8.99 ± 0.20d7.48 ± 0.33 (low)b
Recombinant
8.85g9.79j8.79g
7.50 ± 0.08m9.30 ± 0.10o
9.32 ± 0.04p
9.51 ± 0.03q
9.40 ± 0.10r
9.70s
9.40 ± 0.10t
9.30x
 ImetitNative
10.00e9.09 ± 0.18 (high)b8.99 ± 0.25d9.01c9.31 ± 0.06d9.67 ± 0.06d
10.00g7.02 ± 0.60 (low)b9.50c
9.46 ± 0.10d9.79 ± 0.07v
9.82i
9.53 ± 0.09v
Recombinant9.69j
9.69g9.84 ± 0.03k9.22g
9.38 ± 0.08n9.20 ± 0.05n
10.11 ± 0.10v9.59 ± 0.09k
8.80 ± 0.10o
9.23 ± 0.19q
9.40 ± 0.10r
9.70s
9.59 ± 0.09v
 ImpentamineRecombinant
6.90 ± 0.06m8.84 ± 0.06n
10.11 ± 0.05n8.30 ± 0.10o
8.29 ± 0.14p
8.50 ± 0.10r
 ProxyfanNative
8.51 ± 0.05v8.32 ± 0.13u8.38 ± 0.13v
8.80 ± 0.23u
Recombinant
8.53l8.56l
8.08 ± 0.10n7.90 ± 0.10o
8.62 ± 0.10v8.35 ± 0.06v
8.40 ± 0.20r
7.87 ± 0.07n
 VUF 5296Native
7.60 ± 0.10h
Recombinant
7.17 ± 0.09p
 VUF 5297Native
8.76 ± 0.10e
Recombinant
8.03 ± 0.08p
 MethimepipRecombinant
9.00 ± 0.10o
9.00 ± 0.10x
Imidazole-Containing AntagonistspKi
 ThioperamideNative
8.67a8.37 ± 0.12b8.69a6.61c8.17 ± 0.15d7.13 ± 0.06d
7.99g8.30 ± 0.15y8.34 ± 0.12d7.91 ± 0.10y7.21f
8.10 ± 0.06d8.69 ± 0.05u8.17 ± 0.12aa6.69c
8.12f9.08 ± 0.13u7.18 ± 0.01aa
8.39i8.34 ± 0.11aa
8.85z
8.48 ± 0.01y
8.15 ± 0.06aa
Recombinant
8.37g8.49 ± 0.05y7.19 ± 0.03k7.23g
8.49f7.13f
8.18l7.22l
7.20 ± 0.08m7.34 ± 0.04n
7.94 ± 0.04n7.24 ± 0.06k
8.62 ± 0.06y7.30 ± 0.10o
8.44 ± 0.07aa7.34 ± 0.13q
8.40 ± 0.20bb7.70 ± 0.20r
8.44 ± 0.07cc7.70s
6.90 ± 0.10t
7.85w
7.12 ± 0.10y
7.14 ± 0.06aa
7.40 ± 0.33bb
7.14 ± 0.06cc
 CiproxifanNative
9.15 ± 0.05d9.10 ± 0.16y8.70 ± 0.08d8.20 ± 0.08d6.99 ± 0.08d
9.18f8.76 ± 0.07dd7.46 ± 0.10y7.04f
9.22 ± 0.05v8.24 ± 0.06dd7.05 ± 0.07v
8.91 ± 0.04y6.72 ± 0.14y
9.20 ± 0.04dd7.05 ± 0.06dd
Recombinant
9.36f9.08 ± 0.08y7.18 ± 0.05k7.20f
8.40l7.33l
8.87 ± 0.08n7.03 ± 0.12n
9.38 ± 0.07v7.20 ± 0.04k
9.29 ± 0.05y7.17 ± 0.04q
9.29 ± 0.09cc7.40 ± 0.10r
9.29 ± 0.09dd7.20 ± 0.04v
7.02w
6.96 ± 0.06y
7.20 ± 0.05cc
7.20 ± 0.05dd
 IodoproxyfanNative
9.69i8.86 ± 0.16b9.76 ± 0.23u
10.00 ± 0.09u
Recombinant
9.20 ± 0.10o
 ClobenpropitNative
9.30g9.28 ± 0.16b9.65 ± 0.22d8.65c10.09 ± 0.13d9.08 ± 0.13d
9.38 ± 0.08d9.57 ± 0.09y9.65 ± 0.20aa9.84 ± 0.12y8.24c
9.31i10.09 ± 0.11aa9.11 ± 0.11v
9.45 ± 0.08v9.11 ± 0.11y
9.53 ± 0.11y9.11 ± 0.12aa
9.45 ± 0.08aa
Recombinant
9.39g9.50j9.72 ± 0.10k9.22g
8.85l9.70 ± 0.08y8.61l
8.30 ± 0.02m9.34 ± 0.06n
9.11 ± 0.06n9.43 ± 0.03k
9.82 ± 0.07v8.60 ± 0.10o
9.59 ± 0.09y8.79 ± 0.08q
9.75 ± 0.01aa9.30 ± 0.20r
9.30s
9.47 ± 0.04v
9.23w
9.47 ± 0.19y
9.44 ± 0.04aa
 IodophenpropitNative
9.23 ± 0.10d9.24 ± 0.21b9.39 ± 0.21d9.59 ± 0.09d8.45 ± 0.14d
10.08 ± 0.11u
9.96 ± 0.23u
Recombinant8.20 ± 0.10o
9.10 ± 0.20r
 SCH 79687Native
8.72ee7.88ee
 VUF 5681Recombinant
8.35 ± 0.11p
8.90 ± 0.30r
 BurimamideNative
8.18 ± 0.15d6.28 ± 0.2b8.27 ± 0.05d8.42 ± 0.13d8.34 ± 0.21d
7.16i
Recombinant
7.90 ± 0.10o
Non-imidazole antagonistspKi
 JNJ-5207852Recombinant
8.90 ± 0.17bb9.24 ± 0.21bb
 ABT-239Native
7.92 ± 0.11y7.96 ± 0.08y8.59 ± 0.12ff8.61 ± 0.20y8.34 ± 0.06ff
8.49 ± 0.04ff8.41 ± 0.07ff
Recombinant
8.52 ± 0.08y8.42 ± 0.07y9.51 ± 0.10y
8.87 ± 0.04cc9.35 ± 0.04cc
8.91 ± 0.04ff9.35 ± 0.04ff
 NNC 38-1049Recombinant
8.29gg8.92w
 A-331440Native
7.66f7.64f
7.73 ± 0.08hh7.63 ± 0.05hh
Recombinant
8.20f8.71 ± 0.06k8.48f
8.23 ± 0.04hh8.45 ± 0.05k
7.75 ± 0.04q
8.00r
8.45 ± 0.05hh
 A-349821Native
9.12 ± 0.14hh9.37 ± 0.08hh
Recombinant
8.78 ± 0.12cc9.67 ± 0.14k9.55 ± 0.09k
8.78 ± 0.12hh9.20 ± 0.10r
9.39 ± 0.08cc
9.39 ± 0.08hh
 UCL1972Native
7.41ii
 GSK189254Native
8.51 ± 0.11y8.89 ± 0.13y8.83 ± 0.09y9.59 ± 0.15y
Recombinant
9.17 ± 0.09y8.76 ± 0.06y9.90 ± 0.18y
 PitolisantNative
7.85jj
Recombinant
8.56jj
  • SAMH, S-α-methylhistamine.

  • a Arrang et al., 1987a.

  • e Garbarg et al., 1992.

  • g Lovenberg et al., 2000.

  • d Ireland-Denny et al., 2001.

  • e De Esch et al., 1999.

  • f Hancock et al., 2004a.

  • i Ligneau et al., 1994.

  • l Ligneau et al., 2000.

  • m Drutel et al., 2001.

  • n Schnell et al., 2010.

  • b Jansen et al., 2000.

  • j Chen et al., 2003.

  • c West et al., 1999.

  • k Strakhova et al., 2008.

  • o Lim et al., 2005.

  • p Kitbunnadaj et al., 2003.

  • q Flores-Clemente et al., 2013.

  • r Bongers et al., 2007b.

  • s Lovenberg et al., 1999.

  • t Bongers et al., 2007c.

  • v Krueger et al., 2005.

  • u Harper et al., 1999.

  • w Zaragoza et al., 2004.

  • x Kitbunnadaj et al., 2005.

  • z Sánchez-Lemus and Arias-Montaño, 2004.

  • y Medhurst et al., 2007.

  • aa Esbenshade et al., 2003.

  • bb Barbier et al., 2004.

  • cc Cowart et al., 2005.

  • dd Esbenshade et al., 2004.

  • ee McLeod et al., 2003.

  • ff Esbenshade et al., 2005.

  • gg Malmlöf et al., 2005.

  • hh Hancock et al., 2004b.

  • ii Ganellin et al., 1998.